CLINICAL TRIALS PROFILE FOR FUROSCIX
✉ Email this page to a colleague
All Clinical Trials for FUROSCIX
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04161482 ↗ | An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability | Completed | Clinical Trial Data Services, Inc. | Phase 1 | 2019-12-02 | This is a Phase 1 study to evaluate the safety and tolerability of shortened subcutaneous infusions of Furoscix. |
| NCT04161482 ↗ | An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability | Completed | CSSi Life Sciences | Phase 1 | 2019-12-02 | This is a Phase 1 study to evaluate the safety and tolerability of shortened subcutaneous infusions of Furoscix. |
| NCT04161482 ↗ | An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability | Completed | scPharmaceuticals, Inc. | Phase 1 | 2019-12-02 | This is a Phase 1 study to evaluate the safety and tolerability of shortened subcutaneous infusions of Furoscix. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FUROSCIX
Condition Name
Clinical Trial Locations for FUROSCIX
Trials by Country
Clinical Trial Progress for FUROSCIX
Clinical Trial Phase
Clinical Trial Sponsors for FUROSCIX
Sponsor Name
